Interleukin-receptor antagonist and tumor necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases

Author:

Martí-Carvajal Arturo J123,De Sanctis Juan Bautista4,Dayer Mark5,Martí-Amarista Cristina Elena6,Alegría Eduardo7,Monge Martín Diana7,Abd El Aziz Mohamed8,Correa-Pérez Andrea79,Nicola Susana10,Parise Vasco Juan Marcos10

Affiliation:

1. Facultad de Ciencias de la Salud Eugenio Espejo (Centro Cochrane Ecuador); Universidad UTE; Quito Ecuador

2. Facultad de Medicina (Centro Cochrane Madrid); Universidad Francisco de Vitoria; Madrid Spain

3. Cátedra Rectoral de Medicina Basada en la Evidencia; Universidad de Carabobo; Valencia  Venezuela

4. The Institute of Molecular and Translational Medicine; Palacky University Olomouc, Faculty of Medicine and Dentistry; Olomouc Czech Republic

5. Department of Cardiology; Somerset NHS Foundation Trust; Taunton UK

6. Department of Family Medicine; Northwell Health Southside Hospital; Bay Shore New York USA

7. Faculty of Medicine; Universidad Francisco de Vitoria; Madrid Spain

8. Internal medicine; Texas Tech University Health Sciences Center El PasoPaul L. Foster School of Medicine; El Paso,  Texas USA

9. Clinical Biostatistics Unit; Hospital Universitario Ramón y Cajal (IRYCIS); Madrid Spain

10. Centro Asociado Cochrane Ecuador, Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC); Universidad UTE; Quito Ecuador

Publisher

Wiley

Subject

Pharmacology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3